Cargando…
Novel model combining contrast-enhanced ultrasound with serology predicts hepatocellular carcinoma recurrence after hepatectomy
BACKGROUND: Surgery is the primary curative option in patients with hepatocellular carcinoma (HCC). However, recurrence within 2 years is observed in 30%–50% of patients, being a major cause of mortality. AIM: To construct and verify a non-invasive prediction model combining contrast-enhanced ultras...
Autores principales: | Tu, Hai-Bin, Chen, Li-Hong, Huang, Yu-Jie, Feng, Si-Yi, Lin, Jian-Ling, Zeng, Yong-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409194/ https://www.ncbi.nlm.nih.gov/pubmed/34540956 http://dx.doi.org/10.12998/wjcc.v9.i24.7009 |
Ejemplares similares
-
Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
por: Huang, Jia-Yan, et al.
Publicado: (2020) -
Outcomes of reduction hepatectomy combined with postoperative multidisciplinary therapy for advanced hepatocellular carcinoma
por: Asahi, Yoh, et al.
Publicado: (2021) -
Application value of mixed reality in hepatectomy for hepatocellular carcinoma
por: Zhu, Liu-Yang, et al.
Publicado: (2022) -
Prognostic factors of recurrent intrahepatic cholangiocarcinoma after hepatectomy: A retrospective study
por: Yuan, Zi-Bo, et al.
Publicado: (2022) -
Contrast-enhanced ultrasound imaging for intestinal lymphoma
por: Cui, Ning-Yi, et al.
Publicado: (2021)